Idelalisib Not Yet Recruiting Phase N/A Trials for Chronic Lymphocytic Leukaemia (CLL)

IndicationsStatusPurposePhase
Not Yet RecruitingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03545035Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study